Rationally designed heparinases derived from heparinase I and II and methods of sequencing therewith
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-038/00
C12N-009/88
출원번호
UP-0191144
(2005-07-27)
등록번호
US-7560106
(2009-07-27)
발명자
/ 주소
Sasisekharan, Ram
Shriver, Zachary
Liu, Dongfang
Venkataraman, Ganesh
출원인 / 주소
Massachusetts Institute of Technology
대리인 / 주소
Wolf, Greenfield & Sacks, P.C.
인용정보
피인용 횟수 :
25인용 특허 :
81
초록
Modified heparinases having altered binding specificity and activity are provided. Isolated nucleic acids encoding the same as well as vectors and host cells are provided. Methods for using the modified heparinases are also provided.
대표청구항▼
We claim: 1. A method, comprising: cleaving a glycosaminoglycan, which comprises a disaccharide unit of uronic acid and hexosamine, where the uronic acid is either L-iduronic acid or D-glucuronic acid and the hexosamine is linked to the uronic acid by a 1→4 linkage, with the heparinase of any
We claim: 1. A method, comprising: cleaving a glycosaminoglycan, which comprises a disaccharide unit of uronic acid and hexosamine, where the uronic acid is either L-iduronic acid or D-glucuronic acid and the hexosamine is linked to the uronic acid by a 1→4 linkage, with the heparinase of any one of: a substantially pure heparinase comprising a modified heparinase II, and a substantially pure heparinase comprising a modified heparinase I, wherein the modified heparinase II has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein at least one amino acid residue is substituted and the substitution is selected from the group consisting of (a) a cysteine residue corresponding to position 348 substituted with a different amino acid than in native heparinase II; (b) a histidine residue corresponding to at least one of positions 238, 252, 347, 440, 451, and 579 substituted with alanine, serine, tyrosine, threonine, or lysine; and (c) a conservative substitution of a heparin-binding sequence residue corresponding to at least one of positions 446-451, and wherein the modified heparinase I has the amino acid sequence of the mature peptide of SEQ ID NO: 4, wherein at least one amino acid residue is substituted and the substitution is a seine residue corresponding to position 377 substituted with alanine, serine, tyrosine, histidine, threonine, or lysine; and determining the sequence of the glycosaminoglycan or a cleaved portion thereof. 2. The method of claim 1, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein at least one amino acid residue is substituted and the substitution is selected from the group consisting of (a) a cysteine residue corresponding to position 348 substituted with a different amino acid than in native heparinase II; (b) a histidine residue corresponding to at least one of positions 238, 252, 347, 440, 451, and 579 substituted with alanine, serine, tyrosine, threonine, or lysine; and (c) a conservative substitution of a heparin-binding sequence residue corresponding to at least one of positions 446-451. 3. The method of claim 1, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein the cysteine residue corresponding to position 348 is substituted with a different amino acid than in native heparinase II. 4. The method of claim 3, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein the cysteine residue corresponding to position 348 of SEQ ID NO: 2 is substituted with a residue selected from the group consisting of alanine, serine, tyrosine, histidine, threonine, and lysine. 5. The method of claim 4, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein the cysteine residue corresponding to position 348 of SEQ ID NO: 2 is substituted with alanine. 6. The method of claim 1, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein a histidine residue corresponding to at least one of positions 238, 252, 347, 440, 451, and 579 is substituted with alanine, serine, tyrosine, threonine, or lysine. 7. The method of claim 6, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein the histidine residue corresponding to position 440 is substituted with a residue selected from the group consisting of alanine, serine, tyrosine, threonine, and lysine. 8. The method of claim 1, wherein the heparinase is a modified heparinase II that has the amino acid sequence of the mature peptide of SEQ ID NO: 2, wherein the substitution is a conservative substitution of a heparin-binding sequence residue corresponding to at least one of positions 446-451. 9. The method of claim 1, wherein the heparinase is a modified heparinase I that has the amino acid sequence of the mature peptide of SEQ ID NO: 4, wherein the serine residue corresponding to position 377 of SEQ ID NO: 4 is substituted with a residue selected from the group consisting of alanine, serine, tyrosine, histidine, threonine, and lysine. 10. The method of claim 9, wherein the heparinase is a modified heparinase I that has the amino acid sequence of the mature peptide of SEQ ID NO: 4, wherein the serine residue corresponding to position 377 of SEQ ID NO: 4 is substituted with alanine. 11. The method of claim 1, wherein the glycosaminoglycan is a heparin. 12. The method of claim 1, wherein the glycosaminoglycan is a heparan sulfate. 13. The method of claim 1, wherein the heparinase is immobilized on a solid support.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (81)
Sasisekharan,Ram; Myette,James R.; Shriver,Zachary; Venkataraman,Ganesh, 2-O sulfatase compositions and methods of hydrolyzing therewith.
Shultz John William ; Lewis Martin K. ; Mandrekar Michelle ; Leippe Donna ; Smith ; Jr. Roderick R. ; Welch Roy, Analytical methods and materials for nucleic acid detection.
Filvaroff, Ellen; Goddard, Audrey; Godowski, Paul J.; Grimaldi, J. Christopher; Gurney, Austin L.; Wood, William I., Antibodies against a secreted polypeptide that stimulates release of proteoglycans from cartilage.
Doutremepuich Christian Raymond,FRX ; Saudubray Francois Eugene Pierre Marie,FRX, Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applicatio.
Venkataraman Ganesh (Somerville MA) Sasisekharan Viswanathan (Somerville MA) Sasisekharan Ram (Somerville MA) Bobba Ratnaleela (Somerville MA) Cooney Charles L. (Brookline MA) Langer Robert (Newton M, Computer-implemented process and computer system for estimating the three-dimensional shape of a ring-shaped molecule an.
Findlay Valerie S. (Horsham) Kerry Roger (Horsham) Pay Graham F. (Patcham) Wallis Robert B. (Leechponds Hills) Butler Keith D. (Soreham-by-Sea GB2), Heparin and hirudin antidotal compositions and methods.
Piani Silvano (Bologna ITX) Tamagnone Gianfranco (Casafecchio di Reno ITX) Alpino Raul R. (Bologna ITX) Milani Maria R. (Trebbo di Reno ITX) Fantuz Marinella (Bologna ITX), Heparin derivatives and process for their preparation.
Langer Robert S. (Somerville MA) Linhardt Robert J. (Somerville MA) Cooney Charles L. (Brookline MA) Fitzgerald Gerald (York PA) Grant Arthur (Newton MA), Heparinase derived anticoagulants.
Zimmermann Joseph J. (Elm Grove WI) Lewis N. Tracey (Brossard CAX) Heft Robert A. (Ville St. Laurent CAX), Heparinase free of an anticoagulant component from flavobacterium Heparinum.
Morikawa Kiyoshi (Hinode JPX) Miyazono Hirofumi (Higashiyamato JPX) Maruyama Hiroshi (Higashiyamato JPX) Yoshida Keiichi (Higashimurayama JPX), Heparitinase, process for producing the same and bacteria producing the same.
Zimmerman Joseph J. (Boston MA) Cooney Charles L. (Brookline MA), Large scale method for purification of high purity heparinase from flavobacterium heparinum.
Foley Kevin M. (Franklin OH) Griffin Charles C. (Oxford OH) Amaya Eduardo (Monroe OH), Low molecular weight heparin derivatives having improved anti-Xa specificity.
Griffin Charles C. (710 Melissa Dr. Oxford OH 45056) Foley Kevin M. (5757 Lynn St. Franklin OH 45005) Amaya Eduardo (811 Sands Ave. Monroe OH 45050), Low molecular weight heparin derivatives with improved permeability.
Lormeau Jean-Claude (Maromme FRX) Petitou Maurice (Paris Cedex FRX) Choay Jean (Paris FRX), Low molecular weight heparins of regular structure, their preparation and their biological uses..
Venkataraman,Ganesh; Shriver,Zachary; Raman,Rahul; Sasisekharan,Ram; Keiser,Nishla, Method for identifying or characterizing properties of polymeric units.
Venkataraman,Ganesh; Shriver,Zachary; Raman,Rahul; Sasisekharan,Ram; Keiser,Nishla, Method for identifying or characterizing properties of polymeric units.
Sasisekharan Ramnath (Arlington MA) Moses Marsha A. (Brookline MA) Nugent Matthew A. (Bedford MA) Cooney Charles L. (Brookline MA) Langer Robert S. (Newton MA), Method for inhibiting angiogenesis using heparinase.
Zimmermann Joseph J. (Elm Grove WI) Lewis N. Tracey (Brossard CAX) Heft Robert A. (Ville St. Laurent CAX), Method for the enzymatic neutralization of heparin.
Skubitz Amy P. N. ; Furcht Leo T. ; Balles Mark ; Gregerson Dale S. ; Agarwal Anita ; Wright Martha M. ; Murali Shobana, Method for treating conditions of the eye using polypeptides.
Van Gorp Cornelius L. (Lebanon OH) Wolf Thomas M. (West Chester OH), Method for tumor regression in rats, mice and hamsters using hexuronyl hexosaminoglycan-containing compositions.
Toback F. Gary (Chicago IL) Lieske John C. (Evanston IL), Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells.
Biemann Klaus (Alton Bay NH) Juhasz Peter (Everett MA), Methods and products for mass spectrometric molecular weight determination of polyionic analytes employing polyionic rea.
Sasisekharan,Ram; Venkataraman,Ganesh; Shriver,Zachary; Liu,Dongfang; Sundaram,Mallikarjun; Qi,Yiwei, Methods and products related to the analysis of polysaccarides.
Friedman Jeffrey M. ; Zhang Yiying ; Proenca Ricardo, Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof.
Su Hongsheng (Longueuil CAX) Blain Francoise (Mtl. CAX) Bennett Clark (Pierrefonds CAX) Gu Kangfu (D.D.O. CAX) Zimmermann Joseph (Elm Grove WI) Musil Roy (Carlsbad CA), Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium hepari.
Su Hongsheng,CAX ; Blain Francoise,CAX ; Bennett Clark,CAX ; Gu Kangfu,CAX ; Zimmermann Joseph ; Musil Roy, Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum.
Pecker Iris,ILX ; Vlodavsky Israel,ILX ; Feinstein Elena,ILX, Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells.
Langer Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA) Flanagan Margaret M. (Somerset MA) Klein Michael D. (Ann Arbor MI, Process for neutralizing heparin.
Langer ; Jr. Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA), Process for producing heparinase.
Langer ; Jr. Robert S. (Cambridge MA) Linhardt Robert (Somerville MA) Cooney Charles L. (Brookline MA) Galliher Parrish M. (West Newton MA), Process for producing heparinase.
Nielsen Jorgen I. (Farum DKX), Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight hepar.
Hirsh Jack,CAX ; Shaklee Patrick N. ; Knobloch James E. ; Weitz Jeffrey I.,CAX ; Young Edward,CAX, Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics.
Sasisekharan Ramnath (Arlington MA) Lohse Daniel L. (Bryan TX) Cooney Charles L. (Brookline MA) Linhardt Robert J. (Iowa City IA) Langer Robert S. (Newton MA), Purification of heparinase I, II, and III from Flavobacterium heparinum.
Sasisekharan Ramnath (Arlington MA) Lohse Daniel L. (Bryan TX) Cooney Charles L. (Brookline MA) Linhardt Robert J. (Iowa City IA) Langer Robert S. (Newton MA), Purification, composition and specificity of heparinase I, II, and III from flavobacterium heparinum.
Branellec Jean-Franois (Mont Saint Aignan FRX) Espejo Jose (Bois Guillaume FRX) Picart Philippe (Rouen FRX), Purified heparin fractions, method for obtaining them and pharmaceutical compositions containing them.
Pojasek,Kevin; Raman,Rahul; Sasisekharan,Ram, Rationally designed polysaccharide lyases derived from chondroitinase B and methods of specifically cleaving therewith.
Godavarti Ranganathan ; Sasisekharan Ram ; Ernst Steffen,DKX ; Venkataraman Ganesh ; Cooney Charles L. ; Langer Robert, Rationally designed polysaccharide lyases derived from heparinase I.
Lakowicz Joseph R. ; Burke Thomas G. ; Gryczynski Ignacy ; Malak Henryk, Two-photon and multi-photon measurement of analytes in animal and human tissues and fluids.
Gruskin, Elliott A.; Iaci, Jennifer F.; Vecchione, Andrea M.; Kasperbauer, Sarah J.; Roy, Gargi, Compositions and methods for promoting neuronal outgrowth.
Gruskin, Elliott A.; Iaci, Jennifer F.; Vecchione, Andrea M.; Kasperbauer, Sarah J.; Roy, Gargi, Compositions and methods for promoting neuronal outgrowth.
Gruskin, Elliott A.; Iaci, Jennifer F.; Vecchione, Andrea M.; Kasperbauer, Sarah J.; Roy, Gargi, Compositions and methods for promoting neuronal outgrowth.
Gruskin, Elliott A.; Iaci, Jennifer F.; Vecchione, Andrea M.; Kasperbauer, Sarah J.; Roy, Gargi, Compositions and methods for promoting neuronal outgrowth.
Chandrasekaran, Aarthi; Sengupta, Shiladitya; Berry, David A.; Holley, Kristine; Zhao, Ganlin; Sasisekharan, Ram, Methods and compositions related to the modulation of intercellular junctions.
Liu, Dongfang; Qi, Yiwei; Venkataraman, Ganesh; Sundaram, Mallikarjun; Sasisekharan, Ram, Methods and products related to pulmonary delivery of polysaccharides.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.